NIFTY® and NIFTY® Pro

NIFTY® (Non-Invasive Fetal Trisomy Test) is a modern screening test that safely and accurately identifies the risk of the most common chromosomal abnormalities in the fetus. It is based on next-generation sequencing (NGS) technology and the analysis of fetal cell-free DNA circulating in the mother’s blood. NIFTY® is a proven solution for expectant parents who want accurate, safe, and early information about their child’s health. It is ideal for all pregnant women, regardless of age or pregnancy history.

NIFTY® and NIFTY® Pro are next-generation non-invasive prenatal tests.

Features

•  Safety—a non-invasive method that carries no risk of miscarriage
•  High accuracy—over 99% sensitivity for trisomies 21, 18, and 13
•  Early testing — as early as the 10th week of pregnancy
•  Broad coverage—the ability to screen for up to 137 genetic conditions (optional)
•  Experience — over 13.7 million NIFTY® tests performed in more than 80 countries worldwide
•  Test sample: maternal peripheral blood
•  Technology: Low-coverage whole genome sequencing (WGS)

Key Differences at a Glance

NIFTY® is the best choice for pregnant women who want basic screening for major trisomies with high accuracy and safety. Recommended for pregnant women without additional risk factors.

NIFTY® Pro is an advanced version of the test that offers in-depth screening: all trisomies, sex chromosome aneuploidies, microdeletions, and other genetic abnormalities. Recommended for: pregnant women at increased risk (advanced maternal age, ultrasound abnormalities, family history of genetic disorders) or for those who wish to obtain the most comprehensive information about the fetus’s health.

Targeted mutations and chromosomal abnormalities detected by the NIFTY® and NIFTY® Pro tests